All data are based on the daily closing price as of September 15, 2025
s
Seegene
096530.KQ
18.77 USD
0.07
+0.37%
Overview
Last close
18.77 usd
Market cap
865.75M usd
52 week high
25.81 usd
52 week low
14.21 usd
Target price
30.99 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
2.6446
Price/Book Value
1.2107
Enterprise Value
571.87M usd
EV/Revenue
1.7469
EV/EBITDA
12.2709
Key financials
Revenue TTM
327.37M usd
Gross Profit TTM
196.12M usd
EBITDA TTM
63.64M usd
Earnings per Share
N/A usd
Dividend
0.58 usd
Total assets
895.44M usd
Net debt
N/A usd
About
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.